Erik C. Emerson
Chief Executive Officer at Apimeds Pharmaceuticals US Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2025
2 years of board service in total across 1 board, counting each seat separately. Longest: Apimeds Pharmaceuticals US Inc., 1 year.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 16, 2025 | Apimeds Pharmaceuticals US Inc. | Grant or award | +750,000 | — | — |
Questions about Erik C. Emerson
What boards is Erik C. Emerson on?
Erik C. Emerson sits on the board of Apimeds Pharmaceuticals US Inc.
What company is Erik C. Emerson the CEO of?
Erik C. Emerson has been Chief Executive Officer of Apimeds Pharmaceuticals US Inc. since March 2025.
How long has Erik C. Emerson served on boards?
Our records show at least 2 years of board service across 1 board, the earliest from 2025.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.